Moderna amends U.K. pact for 2M more doses of COVID-19 vaccine

 

• Under its new supply agreement with the United Kingdom's government, Moderna (NASDAQ:MRNA) will supply a total of 7M mRNA-1273 doses to the U.K., beginning in March.
• The company said it's continuing to scale up its global manufacturing to be able to deliver ~500M doses per year and possibly up to 1B doses per year beginning in 2021.
• It's working with manufacturing partners, Lonza (OTCPK:LZAGY) (OTCPK:LZAGF) of Switzerland and ROVI of Spain for manufacturing and fill-finish outside of the U.S. This supply chain will support Europe and countries other than the U.S. that enter into purchase agreements with Moderna.
• Last week the European Commission approved an agreement to secure 80M doses of Moderna's mRNA-1273; under the proposed agreement, the EC has the option to increase its purchase of the vaccine by an additional 80M doses.
• https://seekingalpha.com/news/3639807-moderna-amends-u-k-pact-for-2m-doses-of-covidminus-19-vaccine